Oct 23, 2026
Rivian Acquires AI Simulation Startup to Advance Self-Driving Technology

Rivian Automotive Inc. (NASDAQ:RIVN) announced Thursday that it acquired Third Dimension AI Inc. to strengthen its autonomous driving technology and accelerate the development of advanced driver-assistance systems. The company did not disclose the financial terms of the Oct. 22 acquisition.…

Oct 23, 2026
Micron’s Next AI Memory Breakthrough Has a Cooling Problem

Micron Technology, Inc‘s (NASDAQ:MU) next memory architecture could help AI processors move data faster, but getting more memory closer to compute comes with a physical trade-off: heat. The company’s vertical high-bandwidth memory (vHBM) design aims to increase bandwidth by stacking…

Oct 23, 2026
Why Is Allegion Stock Gaining Friday?

Allegion PLC (NYSE:ALLE) stock rose Friday after the company reported stronger-than-expected third-quarter earnings, raised its full-year outlook and secured an upgrade from Bank of America (BofA), alongside higher price forecasts from other analysts. BofA analyst Rafe Jadrosich upgraded Allegion to…

Oct 23, 2026
CoreWeave Stock Continues to Fall: What’s Happening?

CoreWeave Inc. (NASDAQ:CRWV) shares are breaking to a new 52-week low Friday, its second fresh low in days, as higher rates keep weighing on the stock. CoreWeave stock is testing key support levels. Why is CRWV stock at lows? At…

Oct 23, 2026
Why Is United Airlines Stock Falling on Friday?

United Airlines Holdings Inc. (NASDAQ:UAL) stock fell on Friday as airline stocks traded lower while oil prices rose on expectations that the U.S. could resume strikes on Iran in the coming weeks. Higher oil prices raise fuel costs, which can…

Oct 23, 2026
Two Pills, One Target: Analyst Bets on Pharvaris as Clinical Risks Fade

Bank of America Securities on Friday upgraded Pharvaris N.V. (NASDAQ:PHVS), citing an attractive entry point with clinical risk largely removed. Read Also: Intellia's One-Time Gene Editing Therapy Gains Ground Against Rivals In Rare Swelling Disorder Upgrades Pharvaris On Reduced Clinical…